UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000060121
Receipt number R000068714
Scientific Title A novel strategy for epilepsy focus surgery: identification of epileptogenic zones using seizures induced during awake surgery
Date of disclosure of the study information 2025/12/18
Last modified on 2025/12/18 13:29:16

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study on identifying epileptogenic zones using seizure information obtained during awake surgery

Acronym

Awake Surgery Seizure Study

Scientific Title

A novel strategy for epilepsy focus surgery: identification of epileptogenic zones using seizures induced during awake surgery

Scientific Title:Acronym

ASSIST-EZ Study

Region

Japan


Condition

Condition

Drug-resistant focal epilepsy

Classification by specialty

Neurosurgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To analyze clinical symptoms and electroencephalographic findings of seizures induced by cortical electrical stimulation during awake surgery, and to clarify their relationship with symptomatogenic and epileptogenic zones.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Concordance between symptomatogenic zones identified by seizure symptoms and electroencephalographic findings induced by cortical electrical stimulation during awake surgery, and the final epileptogenic zone.

Key secondary outcomes

Postoperative seizure outcome at 1 year
Occurrence of serious adverse events related to intraoperative electrical stimulation


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification

NO

Dynamic allocation

NO

Institution consideration


Blocking

NO

Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Device,equipment Maneuver

Interventions/Control_1

During awake craniotomy, electrical cortical or intraparenchymal stimulation is performed to provoke seizures or seizure-like activities.
Stimulation is delivered using a cortical mapping stimulator or implanted electrodes at intensities ranging from 2 to 18 mA for several seconds in a stepwise manner.
Continuous intraoperative EEG monitoring is conducted to record after-discharges and clinical seizure symptoms.
If a seizure is induced, stimulation is immediately discontinued and appropriate safety measures, such as cold saline irrigation, are applied.
The intervention is performed only during the surgical procedure.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with drug-resistant focal-onset epilepsy

Patients deemed eligible for awake craniotomy based on preoperative evaluation and EEG conference

Patients undergoing electrical stimulation during awake surgery for epileptogenic zone identification

Or patients who previously underwent awake craniotomy for brain tumor resection in whom seizures were incidentally provoked by cortical stimulation

Key exclusion criteria

Patients considered unsuitable for safe awake surgery due to cognitive, psychiatric, or general medical conditions

Patients in whom responses to intraoperative electrical stimulation are expected to be unrecordable or unevaluable

Patients who do not provide informed consent (by the patient or proxy)

Target sample size

60


Research contact person

Name of lead principal investigator

1st name Yuichi
Middle name
Last name Hirose

Organization

Fujita Health University

Division name

Department of Neurosurgery, School of Medicine

Zip code

470-1192

Address

1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi 470-1192, Japan

TEL

0562-93-9253

Email

yhirose@fujita-hu.ac.jp


Public contact

Name of contact person

1st name Masanobu
Middle name
Last name Kumon

Organization

Fujita Health University

Division name

Department of Neurosurgery, School of Medicine

Zip code

4701192

Address

1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi 470-1192, Japan

TEL

0562939253

Homepage URL


Email

d.m.kumon@gmail.com


Sponsor or person

Institute

Fujita Health University

Institute

Department

Personal name



Funding Source

Organization

Fujita Health University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Board, Fujita Health University

Address

Fujita Health University 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi 470-1192, Japan

Tel

0562-93-9000

Email

f-irb@fujita-hu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 12 Month 18 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2025 Year 04 Month 25 Day

Date of IRB

2026 Year 01 Month 05 Day

Anticipated trial start date

2026 Year 01 Month 05 Day

Last follow-up date

2030 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 12 Month 18 Day

Last modified on

2025 Year 12 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068714